SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Lizard King's Trading Swamp
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TATRADER who wrote (5311)3/20/1998 1:47:00 PM
From: Sandra  Read Replies (1) of 7396
 
Mark,
I heard this was coming ......but, I missed it on cnbc, dont know if it was on yet, but stock is showing huge intrest....Took this off the drmd boards.

<<<CNBC just did a nice bit on Duramed....stock is soaring. All the investment community
had to hear was that Premarin was the most widely prescribed drug in the world, and
that there was no generic equivalent due to FDA claims. In order to be considered
"generic", the chemical structure (including all inert ingredients) must be EXACT. The
generic Duramed wants to push does not contain the "exact" inert substances, from what
has been reported. The FDA, for reasons we all know, considers the inert substances as
"important". Inert ingredients?.....perhaps they should grab a dictionary and look up the
word.>>>>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News